We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $1.96B
1-Year Est. Return 43.61%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
+43.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.52B
AUM Growth
+$61.3M
Cap. Flow
-$261M
Cap. Flow %
-7.42%
Top 10 Hldgs %
30.27%
Holding
462
New
43
Increased
110
Reduced
173
Closed
35

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$40.3M
2
AAP icon
Advance Auto Parts
AAP
+$37.7M
3
AGN
Allergan plc
AGN
+$32.5M
4
NSC icon
Norfolk Southern
NSC
+$32.3M
5
ORLY icon
O'Reilly Automotive
ORLY
+$30.5M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$71.8M
2
META icon
Meta Platforms (Facebook)
META
+$67.6M
3
IDXX icon
Idexx Laboratories
IDXX
+$46.2M
4
TTWO icon
Take-Two Interactive
TTWO
+$43.2M
5
DPZ icon
Domino's
DPZ
+$37.6M

Sector Composition

Rank Sector Weight
1 Technology 30.23%
2 Consumer Discretionary 15.27%
3 Healthcare 14.62%
4 Industrials 13.42%
5 Financials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
201
Ultragenyx Pharmaceutical
RARE
$2.65B
$463K 0.01%
6,070
+1,420
+31% +$115K
MYE icon
202
Myers Industries
MYE
$1.18B
$449K 0.01%
19,310
+900
+5% +$19.3K
ARRY
203
DELISTED
Array Biopharma Inc
ARRY
$424K 0.01%
27,920
+7,400
+36% +$113K
EBS icon
204
Emergent Biosolutions
EBS
$375M
$420K 0.01%
6,377
+5,970
+1,467% +$348K
DAN icon
205
Dana Inc
DAN
$2.91B
$404K 0.01%
21,631
+1,100
+5% +$22.1K
TNL icon
206
Travel + Leisure Co
TNL
$4.54B
$403K 0.01%
10,100
– –
BPMC
207
DELISTED
Blueprint Medicines
BPMC
$371K 0.01%
4,750
+100
+2% +$6.95K
FCBC icon
208
First Community Bankshares
FCBC
$915M
$370K 0.01%
10,914
– –
ICPT
209
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$370K 0.01%
+2,930
New +$310K
BSTC
210
DELISTED
BioSpecifics Technologies Corp.
BSTC
$359K 0.01%
6,144
– –
HCKT icon
211
Hackett Group
HCKT
$245M
$353K 0.01%
17,543
– –
BRSS
212
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$347K 0.01%
9,392
– –
MYGN icon
213
Myriad Genetics
MYGN
$530M
$345K 0.01%
+7,490
New +$333K
WTI icon
214
W&T Offshore
WTI
$545M
$339K 0.01%
35,146
-15,880
-31% -$115K
CCXI
215
DELISTED
ChemoCentryx, Inc.
CCXI
$334K 0.01%
26,447
– –
USPH icon
216
US Physical Therapy
USPH
$1.14B
$329K 0.01%
2,773
-730
-21% -$82.5K
WRLD icon
217
World Acceptance Corp
WRLD
$950M
$327K 0.01%
2,860
– –
IMMU
218
DELISTED
Immunomedics Inc
IMMU
$316K 0.01%
+15,170
New +$359K
LXFR icon
219
Luxfer Holdings
LXFR
$460M
$315K 0.01%
13,535
– –
EBF icon
220
Ennis
EBF
$546M
$311K 0.01%
15,188
+366
+2% +$7.73K
OFG icon
221
OFG Bancorp
OFG
$2.21B
$307K 0.01%
19,017
– –
IRWD icon
222
Ironwood Pharmaceuticals
IRWD
$611M
$306K 0.01%
19,785
+1,433
+8% +$22.7K
HALO icon
223
Halozyme
HALO
$9.72B
$305K 0.01%
16,780
+1,200
+8% +$21K
PCOM
224
DELISTED
Points.com Inc. Common Shares
PCOM
$305K 0.01%
21,717
– –
CVGI icon
225
Commercial Vehicle Group
CVGI
$157M
$283K 0.01%
30,937
– –
7 8
9
10 11

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return

Smith Group Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Smith Group Asset Management held 462 positions worth $3.52B, up 1.8% from $3.46B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Smith Group Asset Management withdrew a net $261M in Q3 2018, closing 35 positions and reducing 173 holdings. Its most notable exit was Idexx Laboratories, an estimated $46.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Smith Group Asset Management opened a new position in Bristol-Myers Squibb worth $42.1M.

  • Smith Group Asset Management's largest Q3 2018 buy was Bristol-Myers Squibb: 678,557 shares worth $42.1M.
  • Smith Group Asset Management added most to Automatic Data Processing in Q3 2018, an estimated $30.5M increase.
  • Smith Group Asset Management's biggest Q3 2018 reduction was McDonald's, cutting an estimated $71.8M.
  • Smith Group Asset Management fully exited Idexx Laboratories in Q3 2018, selling an estimated $46.2M.
  • Smith Group Asset Management's ten largest holdings make up 30% of its $3.52B portfolio in Q3 2018.
  • Smith Group Asset Management opened 43 new positions and closed 35 in Q3 2018.
  • Smith Group Asset Management's portfolio value rose 1.8% quarter-over-quarter to $3.52B.

Based on Smith Group Asset Management's 13F filing for Q3 2018, filed 2 Nov 2018.